===========================================================================


                         UNITED STATES
              SECURITIES AND EXCHANGE COMMISSION
                   Washington, D.C. 20549
                         __________

                          FORM 8-K

                       CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 24, 2005


                     PETMED EXPRESS, INC.
      ----------------------------------------------------
     (Exact name of registrant as specified in its charter)

               Commission file number 000-28827
                                      ---------

          FLORIDA                       65-0680967
   ---------------------------         ------------
  (State or other jurisdiction        (IRS Employer
of incorporation or organization)    Identification No.)


1441 S.W. 29th Avenue, Pompano Beach, Florida      33069
---------------------------------------------    ----------
  (Address of principal executive offices)       (Zip Code)

Registrant's  telephone number, including area code:  (954) 979-5995
                                                      --------------
                      Not Applicable
 -----------------------------------------------------------
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act

[ ] Pre-commencement communications pursuant to Rule 14d-2(b)
    under the Exchange Act

[ ] Pre-commencement communications pursuant to Rule 13e-4(c)
    under the Exchange Act


                                  1




Item 7.01   Regulation FD Disclosure

     On January 24, 2005, PetMed Express, Inc. discussed its
financial results for the quarter ended December 31, 2004.  A
copy of the conference call transcript is attached hereto as
Exhibit 99.1 and is incorporated herein by reference.

     The information furnished in this Item 9, intended to be
furnished under Item 12, is instead furnished under Item 9 in
accordance with SEC Release 33-8216.  This information shall not
be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the "Exchange Act") nor shall
such information be incorporated by reference in any filing under
the Securities Act of 1933, as amended, or the Exchange Act,
except as shall be expressly set forth by specific reference in
such filing.

Item 9.01   Financial Statements and Exhibits

     (c)  Exhibits

99.1 Conference call transcript by PetMed Express, Inc. on January 24, 2005


                                  2




                              SIGNATURES


     Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.


PETMED EXPRESS, INC.
(The "Registrant")

Date: January 26, 2005

By: /s/  Menderes Akdag
    ----------------------------
    Menderes Akdag

    Chief Executive Officer
    (principal executive officer)

By: /s/  Bruce S. Rosenbloom
    -----------------------------
    Bruce S. Rosenbloom

    Chief Financial Officer
    (principal financial and accounting officer)


                                  3




                            EXHIBIT INDEX

Exhibit No.                 Description


99.1    Conference call transcript by PetMed Express on January 24, 2005